Results
52
Companies which are more than 50% undervalued based on analyst price target.
52 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
3037 | NT$139.00 | 0% | -21.0% | NT$212.5b | NT$212.80 | PE26.8x | E62.3% | 2.2% | Tech | ||
1503 | NT$186.50 | 0% | 53.5% | NT$97.2b | NT$290.00 | PE33.7x | E34.9% | 1.6% | Capital Goods | ||
5483 | NT$117.50 | 0% | -38.8% | NT$72.2b | NT$206.75 | PE10.1x | E18.4% | 7.5% | Semiconductors | ||
1795 | NT$258.00 | 0% | -7.7% | NT$68.5b | NT$394.60 | PE15.8x | E21.6% | 1.8% | Pharmaceuticals & Biotech | ||
2344 | NT$14.35 | 0% | -47.2% | NT$64.6b | NT$22.14 | PE73.9x | E136.6% | 0% | Semiconductors | ||
1722 | NT$52.30 | 0% | -23.1% | NT$51.3b | NT$79.00 | PE29.7x | n/a | 5.0% | Materials | ||
6805 | NT$720.00 | 0% | 29.7% | NT$49.4b | NT$1,234.05 | PE49.9x | E56.8% | 0.8% | Tech | ||
4743 | NT$79.00 | 0% | -52.1% | NT$37.7b | NT$234.00 | PS336.2x | E36.8% | 0% | Pharmaceuticals & Biotech | ||
3363 | NT$357.50 | 0% | 390.4% | NT$37.1b | NT$600.00 | PS27.6x | S89.2% | 0.1% | Tech | ||
6589 | NT$80.50 | 0% | -14.5% | NT$24.7b | NT$127.50 | PS21.1x | E40.1% | n/a | Pharmaceuticals & Biotech | ||
4770 | NT$292.00 | 0% | -10.7% | NT$23.4b | NT$445.67 | PE13.8x | E10.8% | 4.1% | Materials | ||
8150 | NT$31.95 | 0% | -25.4% | NT$23.2b | NT$48.67 | PE13.9x | E33.7% | 5.6% | Semiconductors | ||
4147 | NT$84.90 | 0% | -1.3% | NT$23.2b | NT$131.67 | PS37.2x | E26.2% | n/a | Pharmaceuticals & Biotech | ||
5289 | NT$204.50 | 0% | -31.4% | NT$18.7b | NT$388.10 | PE17x | E22.1% | 4.9% | Tech | ||
5213 | NT$30.65 | 0% | -5.6% | NT$18.7b | NT$47.59 | PE39.7x | S71.6% | 5.0% | Real Estate Management and Development | ||
2481 | NT$48.10 | 0% | -22.3% | NT$18.4b | NT$76.50 | PE21.4x | E30.3% | 2.5% | Semiconductors | ||
8478 | NT$193.50 | 0% | -42.7% | NT$18.2b | NT$348.50 | PE10.4x | E7.0% | 6.2% | Consumer Durables | ||
6547 | NT$49.05 | 0% | -18.5% | NT$16.1b | NT$102.00 | PS24.9x | E198.9% | n/a | Pharmaceuticals & Biotech | ||
2031 | NT$47.20 | 0% | -15.4% | NT$15.2b | NT$72.00 | PE8.1x | E-11.6% | 6.4% | Materials | ||
1307 | NT$38.05 | 0% | 44.7% | NT$15.1b | NT$60.00 | PE12.6x | E24.6% | 3.9% | Materials | ||
1436 | NT$118.00 | 0% | 53.6% | NT$14.8b | NT$629.88 | PE4.8x | E-31.5% | 4.7% | Real Estate Management and Development | ||
2231 | NT$102.00 | 0% | -21.2% | NT$14.4b | NT$172.00 | PE69.6x | n/a | 2.9% | Automobiles | ||
6462 | NT$154.50 | 0% | -43.2% | NT$13.7b | NT$260.00 | PS3.1x | S16.8% | 0% | Tech | ||
8936 | NT$53.60 | 0% | -5.1% | NT$13.3b | NT$104.00 | PE17.1x | E35.5% | 2.8% | Capital Goods |